Clinical Trials Logo
  1. Home
  2. H. Pylori Infection
  3. NCT05857163

Efficacy and Safety of Rifasutenizol (TNP 2198) in Participants With H. Pylori Infection

H.Pylori Infection Clinical Trial

Official title:
Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Rifasutenizol (TNP 2198) in Combination With Rabeprazole and Amoxicillin in the Primary Treatment of Participants With H. Pylori Infection

Clinical Trial Summary

A multi-center, randomized, double-blind, bismuth-containing quadruple active comparator-controlled Phase 3 clinical study to evaluate the efficacy and safety of Rifasutenizol in combination with rabeprazole and amoxicillin in the primary treatment of participants with H. pylori infection using an adaptive design with sample size re-estimation. Subjects will be randomly assigned to test group or control group at a 1:1 ratio stratified by study site, and will receive Rifasutenizol capsules, rabeprazole sodium enteric-coated tablets, amoxicillin capsules combined with clarithromycin placebo tablets and bismuth potassium citrate placebo capsules (test group), or bismuth-containing quadruple regimen of amoxicillin capsules, clarithromycin tablets, rabeprazole sodium enteric-coated tablets and bismuth potassium citrate capsules combined with RSZ placebo capsules (control group) for 14 consecutive days. 13C UBT will be performed 4 6 weeks after the last dose to evaluate the eradication effect of H. pylori.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05857163
Study type Interventional
Source TenNor Therapeutics Inc.
Contact
Status Completed
Phase Phase 3
Start date May 18, 2023
Completion date March 26, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04550858 - h.Pylori Ttt With Rebamipide
Completed NCT03650543 - Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication Phase 4
Recruiting NCT04022109 - Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
Not yet recruiting NCT06176547 - Relation of Helicobacter Pylori in Prediabetic Patients
Not yet recruiting NCT06425393 - Intrafamilial Helicobacter Pylori Infection in Hong Kong N/A
Not yet recruiting NCT05882968 - Prevalence of H.Pylori in CKD Patients
Completed NCT03837210 - Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen Phase 2/Phase 3
Completed NCT02332213 - Volatile Markers in Digestive Cancer
Completed NCT03592069 - Concomitant Versus Hybrid Regimen for H. Pylori Eradication Phase 4
Completed NCT06315478 - Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians Phase 4
Not yet recruiting NCT05951998 - Frequency of h.Pylori in Children With Dyspeptic Symptoms
Recruiting NCT06431737 - Comparison of Twice- and Four-times-daily Amoxicillin Administration in 2-week Tegoprazan-based H. Pylori Eradication